Harmony Biosciences discloses updates to board composition and executive compensation structures in a recent 8-K/A filing, marking a shift in corporate governance.
Harmony Biosciences filed an 8-K/A disclosing changes in directors/officers and compensatory arrangements, indicating a management transition with no specified financial impact.
Harmony Biosciences Holdings, Inc. has filed an 8-K/A amendment detailing updates to its board of directors and executive officer structure. The filing also addresses adjustments to compensatory arrangements for key personnel, signaling an ongoing leadership transition within the firm.
The filing indicates formal changes to the company's board of directors and executive officer team, alongside updates to their respective compensatory arrangements.